Haruna Arakawa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Haruna Arakawa has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Akihiro Tojo
Dokkyo Medical University Department of Nephrology & Hypertension Tochigi
1 shared publication - Dedong Kang
Department of Anatomy Showa Medical University Graduate School of Medicine Tokyo Japan
1 shared publication - Kazuho Honda
Department of Anatomy, Showa University School of Medicine, Tokyo, Japan
1 shared publication - Shohei Yokoyama
Department of Nephrology & Hypertension, Dokkyo Medical University, Mibu 321-0293, Japan
1 shared publication - Takehiro Ohira
Department of Nephrology & Hypertension, Dokkyo Medical University, Mibu 321-0293, Japan
1 shared publication - Yoshihiko Ueda
Department of Pathology, Dokkyo Medical University Koshigaya Hospital, 2-1-50 Minamikoshigaya, Koshigaya, Saitama, 343-8555, Japan
1 shared publication
Latest Publications
- Open Access
Juvenile Membranous Nephropathy Developed after Human Papillomavirus (HPV) Vaccination
A 16-year-old girl with no history of renal disease had a fever of 38 °C after her second HPV vaccination and was identified as positive for proteinuria. As she maintained urinary protein of 3.10 g/gCr and 5–9 urinary red blood cells/HPF, a renal biopsy was performed and small spikes on PAM staining with the granular deposition of IgG1++ and IgG3+ on the glomerular capillary wall were discovered by immunofluorescence, although PLA2R immunostaining was negative. Analysis by electron microscope showed electron density deposition in the form of fine particles under the epithelium. The diagnosis was secondary membranous nephropathy stage II. Immunostaining with the anti-p16 INK4a antibody was positive for glomerular cells, and Western blot analysis of urinary protein showed a positive band for p16 INK4a. However, laser-microdissection mass spectrometry analysis of a paraffin section of glomeruli failed to detect HPV proteins. It is possible that the patient was already infected with HPV and administration of the HPV vaccine may have caused secondary membranous nephropathy.
Open AccessJuvenile Membranous Nephropathy Developed after Human Papillomavirus (HPV) Vaccination
A 16-year-old girl with no history of renal disease had a fever of 38 °C after her second HPV vaccination and was identified as positive for proteinuria. As she maintained urinary protein of 3.10 g/gCr and 5–9 urinary red blood cells/HPF, a renal biopsy was performed and small spikes on PAM staining with the granular deposition of IgG1++ and IgG3+ on the glomerular capillary wall were discovered by immunofluorescence, although PLA2R immunostaining was negative. Analysis by electron microscope showed electron density deposition in the form of fine particles under the epithelium. The diagnosis was secondary membranous nephropathy stage II. Immunostaining with the anti-p16 INK4a antibody was positive for glomerular cells, and Western blot analysis of urinary protein showed a positive band for p16 INK4a. However, laser-microdissection mass spectrometry analysis of a paraffin section of glomeruli failed to detect HPV proteins. It is possible that the patient was already infected with HPV and administration of the HPV vaccine may have caused secondary membranous nephropathy.